trending Market Intelligence /marketintelligence/en/news-insights/trending/gZNka5Fo0THYwP7CzPXw-g2 content esgSubNav
In This List

GW Pharmaceuticals closes offering of American depositary shares

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


GW Pharmaceuticals closes offering of American depositary shares

GW Pharmaceuticals plc closed its public offering on the Nasdaq Global Market of 2.4 million American depositary shares at $115 apiece.

The underwriters fully exercised their option to buy an additional 360,000 ADSs at the offering price.

Gross proceeds from the offering totaled about $317.4 million.

Goldman Sachs & Co. LLC, Morgan Stanley, Bank of America Merrill Lynch and Cowen acted as joint book-running managers for the offering.